论文信息 - Durvalumab in frail and elder patients with stage four NSCLC: Study protocol of the randomized phase II DURATION trial - 字舞流文

Durvalumab in frail and elder patients with stage four NSCLC: Study protocol of the randomized phase II DURATION trial

A. Stenzinger | Michael Thomas | F. Lasitschka | M. Kieser | J. Krisam | F. Bozorgmehr | M. Schneider | A. Hommertgen | M. Blasi | J. Kuon | M. Maenz